Literature DB >> 1610969

Survival for lung cancer in northern Italy.

M Sant1, G Gatta, R Capocaccia, A Verdecchia, A Micheli, D Speciale, U Pastorino, F Berrino.   

Abstract

From the population covered by the Lombardy Cancer Registry (northern Italy), all 2,259 lung cancer patients diagnosed from 1976 to 1981 were followed through 30 November 1989. The length of follow-up ranged from eight to 13 years. A special investigation on long-term survivors showed that a negligible proportion (0.01 percent) of errors occur in determining life status when an active follow-up is adopted. Age, stage, and histotype were found to be statistically significant, independent, prognostic factors in multivariate analysis both by the Cox model and by a model considering the relative survival. Observed survival was 29 percent at one year after diagnosis, 13 percent at two years, eight percent at three years, five percent at five years and two percent at 10 years. Survival decreased with age, but the youngest patients of both sexes showed lower survival compared with immediately subsequent ages. Among morphologically confirmed tumors, epidermoid carcinomas and adenocarcinomas showed the highest survival (38 percent and 33 percent at one year, respectively); small cell carcinomas showed the poorest prognosis (one-year survival, 23 percent). Beyond the second year after diagnosis, differences between histotypes became slighter. Survival according to stage showed a decreasing pattern from limited to advanced tumors, one-year figures being 41 percent for localized tumors, 27 percent for regional metastasis, and three percent for distant metastasis. Relative survival in Varese was compared with that reported by other cancer registries in Western countries: the variability noted could be related to different modalities of registration and to different distribution of clinical and demographic factors.

Entities:  

Mesh:

Year:  1992        PMID: 1610969     DOI: 10.1007/bf00124255

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  12 in total

1.  Management of lung cancer.

Authors:  S G Spiro
Journal:  BMJ       Date:  1990-12-08

2.  Relative survival and the estimation of net survival: elements for further discussion.

Authors:  J Estève; E Benhamou; M Croasdale; L Raymond
Journal:  Stat Med       Date:  1990-05       Impact factor: 2.373

3.  Thirty years of surgery for carcinoma of the bronchus.

Authors:  J R Belcher
Journal:  Thorax       Date:  1983-06       Impact factor: 9.139

4.  Survival of cancer patients in Finland in 1953-1974.

Authors:  T Hakulinen; E Pukkala; M Hakama; M Lehtonen; E Saxén; L Teppo
Journal:  Ann Clin Res       Date:  1981

5.  Expanded possibilities for surgical treatment of lung cancer. Survival in stage IIIa disease.

Authors:  C F Mountain
Journal:  Chest       Date:  1990-05       Impact factor: 9.410

6.  Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983.

Authors:  C K Connolly; W G Jones; J Thorogood; C Head; M F Muers
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

7.  Classifying clinical severity to help solve problems of stage migration in nonconcurrent comparisons of lung cancer therapy.

Authors:  D G Pfister; C K Wells; C K Chan; A R Feinstein
Journal:  Cancer Res       Date:  1990-08-01       Impact factor: 12.701

8.  Survival of patients with cancer of the stomach, colon and rectum, lung and breast in Ragusa, Sicily.

Authors:  L Gafà; P Amendola; G Dardanoni; L Dardanoni
Journal:  Tumori       Date:  1991-02-28

9.  Survival of histologically proven carcinoma of the lung registered in the North West Thames Region, 1975-1979.

Authors:  R F Mould; R J Williams
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

10.  Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-86.

Authors:  S W Watkin; G K Hayhurst; J A Green
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

View more
  2 in total

1.  Divergent changes in survival for histological types of non-small-cell lung cancer in the southeastern area of The Netherlands since 1975.

Authors:  M L Janssen-Heijnen; R M Schipper; P J Klinkhamer; M A Crommelin; W J Mooi; J W Coebergh
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

2.  Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France.

Authors:  P Grosclaude; J P Galat; J Macé-Lesech; M Roumagnac-Machelard; M Mercier; J Robillard
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.